World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: TCTR
Last refreshed on: 29 April 2024
Main ID:  TCTR20140224006
Date of registration: 24/02/2014
Prospective Registration: Yes
Primary sponsor: Faculty of medicine, Chiang Mai University
Public title: The effect of different groups of progestin on sleeping of menopausal women
Scientific title: The effect of different groups of progestin on sleeping of menopausal women
Date of first enrolment: 03/03/2014
Target sample size: 100
Recruitment status: Pending (Not yet recruiting)
URL:  https://www.thaiclinicaltrials.org/show/TCTR20140224006
Study type:  Interventional
Study design:  Randomized  
Phase:  N/A
Countries of recruitment
Thailand
Contacts
Name: Ekachai    Leeangkoonsathian
Address:  Department of obstetrics and gynaecology, Maharaj Nakorn Chiang Mai Hospital 50200 Chiang Mai Thailand
Telephone: +66891754641
Email: excerp@gmail.com
Affiliation:  Department of obstetrics and gynaecology, Maharaj Nakorn Chiang Mai Hospital
Name: Ekachai    Leeangkoonsathian
Address:  110 Intrawaroroj Road, Sri Phum 50200 Chiang Mai Thailand
Telephone: +66891754641
Email: excerp@gmail.com
Affiliation:  Department of obstetrics and gynaecology, Maharaj Nakorn Chiang Mai Hospital
Key inclusion & exclusion criteria
Inclusion criteria: New menopausal patients at Maharaj Nakorn Chiang Mai Hospital
suitable for estrogen plus progesterone treatment

Exclusion criteria: contraindication for hormone replacement therapy
recently use sleep drug
recently use psychotic drug


Age minimum: 40 Years
Age maximum: 65 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Menopausal and Postmenopausal Disorders
Sleeping quality
menopause
climacteric
progestin
dydrogesterone
micronized progesterone
Sleeping quality
menopause
climacteric
progestin
dydrogesterone
micronized progesterone
Intervention(s)
1 mg 17 beta-estradiol plus 100 mg micronized progesterone oral once a day for 3 months.,1mg 17 beta-estradiol plus 10 mg dydrogesterone oral once a day for 3 months.
Experimental Drug,Experimental Drug
micronized progesterone,dydrogesterone
Primary Outcome(s)
Improving of sleeping quality (assessed by the PSQI score) Patient reported outcome using a questionnaire interview
Secondary Outcome(s)
The side effect and climacteric symptoms comparing between 2 arms. Patient reported outcome using a questionnaire interview
Secondary ID(s)
Source(s) of Monetary Support
Faculty of medicine, Chiang Mai University
Secondary Sponsor(s)
Reproductive medicine unit, Obsterics and Gynecology department, Maharaj Nakon Chiang Mai Hospital
Ethics review
Status: Submitted, approved
Approval date:
Contact:
Research Ethics Committee 4
+6653-94-6204 Ext.
Results
Results available:
Date Posted:
Date Completed: 30/04/2015
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history